Ligation of TLR7 on CD19 + CD1d hi B cells suppresses allergic lung inflammation via regulatory T cells
2015; Wiley; Volume: 45; Issue: 6 Linguagem: Inglês
10.1002/eji.201445211
ISSN1521-4141
AutoresAdnan R. Khan, Sylvie Amu, Sean P. Saunders, Emily Hams, Gordon Blackshields, Martin O. Leonard, Casey T. Weaver, Tim Sparwasser, Orla Sheils, Padraic G. Fallon,
Tópico(s)IL-33, ST2, and ILC Pathways
ResumoB cells have been described as having the capacity to regulate cellular immune responses and suppress inflammatory processes. One such regulatory B-cell population is defined as IL-10-producing CD19(+) CD1d(hi) cells. Previous work has identified an expansion of these cells in mice infected with the helminth, Schistosoma mansoni. Here, microarray analysis of CD19(+) CD1d(hi) B cells from mice infected with S. mansoni demonstrated significantly increased Tlr7 expression, while CD19(+) CD1d(hi) B cells from uninfected mice also demonstrated elevated Tlr7 expression. Using IL-10 reporter, Il10(-/-) and Tlr7(-/-) mice, we formally demonstrate that TLR7 ligation of CD19(+) CD1d(hi) B cells increases their capacity to produce IL-10. In a mouse model of allergic lung inflammation, the adoptive transfer of TLR7-elicited CD19(+) CD1d(hi) B cells reduced airway inflammation and associated airway hyperresponsiveness. Using DEREG mice to deplete FoxP3(+) T regulatory cells in allergen-sensitized mice, we show that that TLR7-elicited CD19(+) CD1d(hi) B cells suppress airway hyperresponsiveness via a T regulatory cell dependent mechanism. These studies identify that TLR7 stimulation leads to the expansion of IL-10-producing CD19(+) CD1d(hi) B cells, which can suppress allergic lung inflammation via T regulatory cells.
Referência(s)